Farther Finance Advisors, LLC Ligand Pharmaceuticals Inc Transaction History
Farther Finance Advisors, LLC
- $2.06 Trillion
- Q2 2024
A detailed history of Farther Finance Advisors, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 702 shares of LGND stock, worth $71,330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
702
Previous 77
811.69%
Holding current value
$71,330
Previous $5.67 Million
951.09%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LGND
# of Institutions
247Shares Held
17.5MCall Options Held
61KPut Options Held
7.8K-
Black Rock Inc. New York, NY2.87MShares$292 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$196 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$102 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3967KShares$98.2 Million0.1% of portfolio
-
Dimensional Fund Advisors LP Austin, TX709KShares$72 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.72B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...